circulating tumor DNA Foresight Diagnostics Commercializing PhasED-Seq Liquid Biopsy Tech for Improved MRD Detection Premium The technology, developed by researchers at Stanford, showed strong performance in a new study of lymphoma, and early data for solid tumors is already available. Natera Minimal Residual Disease Test Predicts Oligometastatic CRC Patient Outcomes in New Study Premium Investigators analyzed blood samples from patients at two time points after curative-intent surgery, finding that ctDNA MRD status was highly predictive of outcome. Natera Aims to Lead Market in Solid Tumor Adjuvant CDx, Supported by New Liquid Biopsy Data Premium A new publication detailing ctDNA testing results has spurred a minimal residual disease biomarker-directed trial for Roche's atezolizumab in bladder cancer. Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications Research presented at the ASCO meeting described efforts to expand the use of existing technologies into new directions. Liquid Biopsy-Guided EGFR Rechallenge Therapy Shows Benefit for Colorectal Cancer Patients The first interventional trial to use ctDNA to recruit eligible patients for this treatment showed 30 percent observable responses and more than 60 percent disease control. Jun 2, 2021 Foresight Diagnostics Raises $12.5M in Series A to Commercialize MRD Detection Tech May 25, 2021 F-Star Therapeutics to Use Inivata's RaDaR Assay in Clinical Studies May 19, 2021 Caris Life Sciences, Fueled by New Funding, Plans to Expand Liquid Biopsy Testing Premium May 19, 2021 Colorectal Cancer Relapse Can Be Predicted by ctDNA Clearance, Study Shows May 18, 2021 Sutter Health Exploring In-House ctDNA Testing in Effort to Expand Precision Oncology Access Premium May 11, 2021 Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer May 7, 2021 Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape Premium Apr 28, 2021 NuProbe, AcornMed to Develop Cancer Minimal Residual Disease Detection Products Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Apr 15, 2021 OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer Apr 14, 2021 Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries Apr 13, 2021 FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines Premium Apr 8, 2021 Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx Premium Apr 2, 2021 Illumina Parries FTC Challenge to Grail Acquisition With Deals for Competing Customers Premium Apr 1, 2021 Guardant Health Receives New York State Approval for Guardant Reveal MRD Test Mar 31, 2021 Delfi Diagnostics Starts Prospective Lung Cancer Screening Trial Mar 29, 2021 Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag Mar 29, 2021 Barbara Ann Karmanos Cancer Institute Receives $325K Lymphoma Research Grant Mar 27, 2021 Liquid Biopsy MRD Detection Eyed as Decision Tool for Oligometastatic Colorectal Cancer Patients Premium Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Load More Breaking News Analysis of Ancient Plaque Points to Agriculture-Related Oral Microbiome Changes in Southern Europe Gene-Disrupting Ultra-Rare Variants More Common in Children With Autism Spectrum Disorder CDC to Withdraw EUA for COVID-19 Test; FDA Revokes Three Other EUAs for Non-Use, Agency Clearance Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business Top Five Articles on GenomeWeb Last Week: Pacific Biosciences, Illumina, Natera, and More Canine Genetics Firm Embark Veterinary Raises $75M in Series B Round The Scan Purnell Choppin Dies Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post. Effectiveness May Decline, Data From Israel Suggests The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high. To See Future Risk Slate looks into the use of polygenic risk scores in embryo screening. PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.